Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-23-000274

Options or other derivatives

  • Symons Julian A. acquired 48,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Symons Julian A.

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-08 Grant or award : show line 1 in the form Stock Option (Right to Buy) +48,000 48,000 D
Loading xslF345X05/form4.xml…